药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Pirbuterol
Amifampridine
The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Amifampridine.
Pirbuterol
Benidipine
The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Benidipine.
Pirbuterol
Melperone
The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Melperone.
Pirbuterol
Lenvatinib
The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Lenvatinib.
Pirbuterol
Butriptyline
The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Butriptyline.
Pirbuterol
Eperisone
The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Eperisone.
Pirbuterol
Fendiline
The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Fendiline.
Pirbuterol
Bedaquiline
The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Bedaquiline.
Pirbuterol
Antazoline
The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Antazoline.
Pirbuterol
Nilvadipine
The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Nilvadipine.
Pirbuterol
Nemonoxacin
The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Nemonoxacin.
Pirbuterol
Telavancin
The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Telavancin.
Pirbuterol
Tucidinostat
The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Tucidinostat.
Pirbuterol
Tedisamil
The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Tedisamil.
Pirbuterol
Garenoxacin
The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Garenoxacin.
Pirbuterol
Technetium Tc-99m ciprofloxacin
The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Technetium Tc-99m ciprofloxacin.
Pirbuterol
Pracinostat
The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Pracinostat.
Pirbuterol
Azimilide
The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Azimilide.
Pirbuterol
Fluspirilene
The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Fluspirilene.
Pirbuterol
Prenylamine
The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Prenylamine.